Hims & Hers added eight new partners, expanding its Benefits program across fitness, nutrition, glucose monitoring, women's health and sleep. ・The company recently launched generic Semaglutide in ...

Former Netflix CFO and Hims board member David Wells bought 48,400 shares worth about $1.17 million. ・Investor concerns intensified after Hims reported weak Q1 results that missed revenue and earnings ...

Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Value Investor model based on the published strategy of ...

Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him ...

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after the bell. Here’s what to expect.

Hims & Hers Health (NYSE: HIMS) stock crashed 25% through 10:45 a.m. ET Monday morning after an eventful weekend. Where to invest $1,000 right now? Our analyst team just revealed what they believe are ...

Telehealth company Hims & Hers Health (NYSE:HIMS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 3.8% year on year to $608.1 million. On the other hand, next quarter’s outlook ...

NEW YORK, March 2 (Reuters) - Telehealth company Hims & Hers Health, known for its weight-loss ⁠drug ⁠business, is promising it can diversify away from its ⁠reliance on compounded GLP-1 sales in the U ...